Table 3.
Outcomes of transarterial embolization and surgery
| Overall (n = 59) | Bleeding (n = 23) | Non‐bleeding (n = 36) | |
|---|---|---|---|
| TAE | |||
| No. of sessions required | |||
| 1 | 36 (61) | 13 (57) | 23 (64) |
| 2 | 6 (10) | 2 (9) | 4 (11) |
| 3 | 5 (8) | 2 (9) | 3 (8) |
| 4 | 1 (2) | 0 (0) | 1 (3) |
| Not reported | 11 (19) | 6 (26) | 5 (14) |
| Duration of hospital stay (days)* | 3·0 (1·0–10·5) | 12·0 (4·8–18·3) | 2·0 (1·0–5·0) |
| Surgery | 20 (34) | 7 (30) | 13 (36) |
| Indication for surgery | |||
| Persisting size | 9 (45) | 1 (14) | 8 (62) |
| Bleeding | 4 (20) | 4 (57) | 0 (0) |
| HCC suspected | 3 (15) | 1 (14) | 2 (15) |
| Growth | 2 (10) | 0 (0) | 2 (15) |
| Persisting symptoms | 1 (5) | 0 (0) | 1 (8) |
| Pregnancy wish | 1 (5) | 1 (14) | 0 (0) |
| Type of surgery | |||
| Open segment resection | 9 (45) | 4 (57) | 5 (38) |
| Open hemihepatectomy | 6 (30) | 2 (29) | 4 (31) |
| Laparoscopic hemihepatectomy | 5 (25) | 1 (14) | 4 (31) |
| Perioperative complications | |||
| None | 18 (90) | 6 (86) | 12 (92) |
| Bleeding | 2 (10) | 1 (14) | 1 (8) |
| Postoperative complications | |||
| None | 14 (70) | 3 (43) | 11 (85) |
| Bleeding (Clavien–Dindo I) | 2 (10) | 2 (29) | 0 (0) |
| Abscess (Clavien–Dindo III) | 2 (10) | 2 (29) | 0 (0) |
| Thrombosis (Clavien–Dindo II) | 1 (5) | 0 (0) | 1 (8) |
| Thrombosis and sepsis (Clavien–Dindo II) | 1 (5) | 0 (0) | 1 (8) |
| Duration of hospital stay (days)* | 10·0 (7·5–11·0) | 10·0 (10·0–41·0) | 8·0 (4·0–10·0) |
| Incisional hernia† | 2 (10) | 1 (14) | 1 (8) |
Values in parentheses are percentages unless indicated otherwise;
*
values are median (i.q.r.).
†
All symptomatic. TAE, transarterial embolization.